Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - cabergoline - oral tablet - 2mg

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - cabergoline -

Ísrael - enska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - cabergoline - tablets - cabergoline 0.5 mg - cabergoline - cabergoline - treatment of hyperprolactinemic disorders.dostinex is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. dostinex is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - cabergoline - oral tablet - 1mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - cabergoline - oral tablet - 1mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - cabergoline - oral tablet - 1mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - cabergoline - oral tablet - 1mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - cabergoline - oral tablet - 1mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - cabergoline - oral tablet - 1mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - cabergoline - oral tablet - 1mg